Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales

As a result of increased software sales by the acquirer, and in accordance with the terms of the software business sale agreement, a significant number of zero-exercise-price warrants have matured—Blade Ranger now holds approximately 1 million shares and warrants exercisable at no additional cost

TEL AVIV, Israel, May 27, 2025 /PRNewswire/ -- Blade Ranger Ltd. (TASE: BLRN), a company listed on the Tel Aviv Stock Exchange, announced the achievement of a first milestone in the transaction involving the sale of its DeepSolar operations to PainReform (NASDAQ: PRFX).

According to the agreement, which was completed in March 2025, Blade Ranger received a package of securities that included, among other things, common shares of PainReform representing approximately 9.9% of the company's equity, as well as approximately 3.08 million warrants convertible into common shares, some of which are subject to milestone achievements.

Now, as a result of reaching the first milestone, the company has received 685,004 warrants exercisable at an exercise price of $0.01 per share, while PainReform's  shares are currently trading at approximately $1.91. Following receipt of these warrants, Blade Ranger holds shares and warrants (with a $0.01 exercise price) worth approximately $2 million based on the share price at the time of this announcement.

Blade Ranger's CEO commented:
"The continued success of PainReform's software sales, which led to the maturity of additional warrants, significantly improves the company's financial flexibility and supports the accelerated business development we are driving forward."

The market value of the shares that may be derived from the matured warrants, based on the current share price, is approximately NIS 4.5 million.

SOURCE Blade Ranger Ltd.